Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Biomédica
versão impressa ISSN 0120-4157
Resumo
CONTRERAS, Kateir et al. Cost-effectiveness of two prevention cytomegalovirus infection schemes in renal transplant patients at intermediate risk in Colombia. Biomédica [online]. 2018, vol.38, n.1, pp.77-85. ISSN 0120-4157. https://doi.org/10.7705/biomedica.v38i0.3613.
Introduction:
Cytomegalovirus (CMV) is the most frequent opportunistic infection after renal transplantation. There are two strategies for its prevention: Universal prophylaxis, with valganciclovir for 90 days, and anticipated therapy, using weekly viral load surveillance, and therapy only if positive. Meta-analysis directly comparing both strategies have shown them to have similar effectiveness.
Objective:
To determine which strategy is more cost-effective in intermediate risk patients in Colombia.
Materials and methods:
We designed a third-party payer perspective decision tree, considering only direct medical costs in 2014 Colombian pesos (COP) (USD$ 1=COP$ 2,000) and a time horizon of one year. The target population was intermediate CMV risk patients (positive receptor). Transition probabilities were extracted from clinical studies, validated with a Delphi expert panel method; procedural costs were obtained from the ISS 2001 manual with a 33% increment based on the Consumer Price Index for 2014, while medication costs were obtained from the official Ministry of Health information system.
Results:
Universal prophylaxis with valganciclovir was dominant, with lower costs and less probability of infection. The average cost of the first year in anticipated therapy would be COP$ 30,961,290, whereas in the case of universal therapy the cost would be COP$ 29,967,834 (incremental cost of COP$ 993,456).
Conclusions:
For Colombian renal transplant patients at intermediate risk for CMV infection, universal prophylaxis strategy is the best option.
Palavras-chave : Cytomegalovirus; costs and cost analysis; kidney transplantation; disease prevention; immunosuppression; Colombia.